In the ever-evolving landscape of probiotics, the focus is shifting from mere delivery to addressing the intricate biological challenges that underpin gut health. This paradigm shift, as highlighted by Lucas Chang, R&D Manager at TCI, underscores the importance of traceability and functionality in probiotic development. Chang's insights at the Growth Asia Summit 2026 reveal a profound understanding of the gut-axis and the multifaceted nature of aging, offering a fresh perspective on how probiotics can be engineered to combat specific health challenges.
The Evolution of Probiotic Delivery
Chang's perspective on probiotic delivery is a departure from traditional engineering logic. Historically, the primary concern was ensuring the survival and arrival of probiotics in the intestine. However, as Chang points out, the journey begins with arrival, and the real challenge lies in understanding the context, ecosystem, and function that follow. This shift in focus towards traceability is crucial, especially in the context of gut-axis science, which encompasses the gut-brain, gut-liver, gut-skin, and gut-muscle connections.
The concept of the 'evidence chain' is pivotal here. It involves tracing microbiome function, bioactive compound production, host response, and measurable impact at distant sites. This traceability is essential for establishing a clear probiotic mechanism, particularly in the context of healthy aging, where the body's response to pressure and biological challenges evolves over time.
Aging and the Gut: A Dynamic Relationship
Aging, according to Chang, is not a uniform process with a constant decline in biological function. Instead, it is characterized by distinct pressure points that emerge at different stages of life. A longitudinal multi-omics study, cited by Chang, revealed two critical checkpoints. The first occurs around the 40s, involving changes in lipid metabolism, alcohol metabolism, and cardiovascular health. The second transition happens around 60, focusing on immune regulation, carbohydrate metabolism, oxidative stress, and related pathways.
This dynamic nature of aging implies that two individuals of the same chronological age can experience vastly different functional trajectories. One might be planning travels, while the other schedules doctor's appointments. This highlights the importance of resilience and the body's ability to handle and recover from biological challenges between these pressure points.
Probiotics and Aging Stresses
Two common aging stresses, fat accumulation and alcohol consumption, present unique challenges. Fat accumulation is a chronic metabolic pressure that builds up over time, while alcohol poses an acute challenge within hours. TCI's response to these challenges is the development of TCR711, a patented spore-forming probiotic strain.
In a randomized, placebo-controlled study involving adults with non-alcohol fatty liver disease (NAFLD), TCR711 demonstrated significant improvements in liver-fat outcomes compared to the placebo group. The study also revealed shifts in gut ecology, suggesting that the probiotic's impact extends beyond the liver. This finding aligns with the idea that the gut ecosystem plays a pivotal role in lipid metabolism, as evidenced by the production of short-chain fatty acids (SCFAs) by specific microbial strains.
Engineering Probiotics for Specific Functions
Chang emphasizes that engineering functional probiotics involves more than just delivery; it requires a deep understanding of the desired outcome. This approach changes the product design process, starting with the health outcome and functions to be altered. By tracing the biology backward, defining the microbial job, and then building the probiotic strain, function, and delivery around it, TCI creates targeted solutions.
The concept of 'matrix engineering' is introduced, where the probiotic is not forced into a supplement format but rather integrated into everyday life. Chang showcases this with the application of TCI's probiotic in liquid chocolate, a format that not only enhances survival but also builds daily habits. This approach challenges the notion that advanced probiotic delivery should begin with forcing probiotics into supplement formats, instead suggesting that the answer might already be present in our daily lives.
Conclusion: A New Era of Probiotic Innovation
In conclusion, the future of probiotics is about more than just delivering live bacteria to the gut. It involves understanding the complex biological challenges that underpin gut health and aging, and engineering probiotics to address these challenges effectively. TCI's approach, as exemplified by TCR711 and liquid chocolate probiotic, represents a new era of probiotic innovation, where functionality and traceability are at the forefront. This shift not only promises to revolutionize probiotic delivery but also offers a more holistic and personalized approach to health and wellness.
